Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity (Tables)

v3.20.2
Stockholders' equity (Tables)
3 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of warrants or rights
The activity related to warrants during for the three months ended September 30, 2020, is summarized as follows:
 
     Common
Stock from
Warrants
     Weighted-
average
Exercise
Price (per share)
 
Outstanding at July 1, 2020
     145,421      $ 29.48  
Granted
     —          —    
Exercised
     —          —    
Forfeited
     (38,326      82.50  
Outstanding and exercisable at September 30, 2020
     107,095      $ 10.50  
  
 
 
    
 
 
 
Schedule of equity awards
The activity related to equity awards, which comprised of stock options during the three months ended September 30, 2020, is summarized as follows:
 
     Stock
Options
     Weighted-
average
Exercise
Price
    
Weighted-average

Remaining
Contractual Term
     Aggregate
Intrinsic Value
 
Outstanding at June 30, 2020
     70,161      $ 60.42        2.89 years      $ —    
Granted
     —          —          
Exercised
     —          —          
Forfeited
     (444      69.32        
  
 
 
    
 
 
       
Outstanding at September 30, 2020
     69,717        60.00        2.65 years        —    
Exercisable at September 30, 2020
     43,273      $ 68.53        2.26 years      $ —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of share-basedcompensation expense
The classification of share-based compensation expense for the three months ended:
 
    
Three Months Ended
 
(US$’000)
  
September 30,
 
    
2020
    
2019
 
Research and development
   $ 9      $ (17
General and administrative
     29        72  
  
 
 
    
 
 
 
Total share-based compensation expense
   $ 38      $ 55